Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

440.94
Delayed Data
As of Oct 19
 +1.57 / +0.36%
Today’s Change
325.35
Today|||52-Week Range
543.55
+20.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
AssetsCash920.4M535.2M811.8M744.3M
 
 
 
 
 
Short Term Investment Cash273.9M-385.2M276.6M-67.5M
 
 
 
 
 
Cash & Short Term Investments1.4B1.0B1.3B1.3B
 
 
 
 
 
 
ReceivablesReceivables1.6B1.6B1.7B1.8B
 
 
 
 
 
 
InventoriesInventories345.6M399.4M466.6M554.3M
 
 
 
 
 
 
Current AssetsOther Current Assets103.8M130.5M146.1M193.3M
 
 
 
 
 
Current Assets3.5B3.2B3.7B3.9B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross--2.5B----
 
 
Depreciation---425.5M----
 
 
Other Assets20.7M20.3M37.1M37.0M
 
 
 
 
 
Total Assets6.8B7.0B7.8B8.1B
 
 
 
 
 
 
LiabilitiesAccounts Payable124.5M135.0M141.8M151.4M
 
 
 
 
 
Short Term Debt0.00127.3M7.2M0.00
 
 
 
Accrued Expenses295.2M355.3M375.1M395.3M
 
 
 
 
 
Other Current Liabilities541.5M590.4M614.4M708.0M
 
 
 
 
 
Other Liabilities961.2M1.2B1.3B1.0B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt382.2M351.6M700.4M701.2M
 
 
 
 
 
Deferred Taxes-655.6M-825.3M-866.3M-883.0M
 
 
 
 
 
Other Liabilities135.7M100.4M106.2M115.9M
 
 
 
 
 
Total Liabilities2.3B2.5B3.0B2.6B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity4.5B4.4B4.9B5.5B
 
 
 
 
 
Total Shareholder Equity4.5B4.4B4.9B5.5B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding105.5M106.0M106.3M107.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.